APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paclitaxel and Docetaxel

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Paclitaxel and Docetaxel Industry Growth and Trends Forecast to 2032

31 December 2025104 pages

Choose your research edition.

Industry ResearchPaclitaxel and Docetaxel Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Paclitaxel and Docetaxel Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Paclitaxel and Docetaxel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paclitaxel and Docetaxel Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Paclitaxel and Docetaxel Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Paclitaxel and Docetaxel market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Paclitaxel and Docetaxel is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Paclitaxel and Docetaxel is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Paclitaxel and Docetaxel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Paclitaxel and Docetaxel include Yunnan Hande, Southpharma, Hainan Yew Pharm, TAPI (Teva), ScinoPharm, Samyang, Polymed, Phyton and Novasep, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Paclitaxel and Docetaxel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Paclitaxel and Docetaxel market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Paclitaxel and Docetaxel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Paclitaxel and Docetaxel.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Paclitaxel and Docetaxel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Paclitaxel and Docetaxel Market by Company

Yunnan Hande

Southpharma

Hainan Yew Pharm

TAPI (Teva)

ScinoPharm

Samyang

Polymed

Phyton

Novasep

Jiangsu Yew Biotechnology

Huiang biopharma

Fresenius-kabi

Paclitaxel and Docetaxel Segment by Type

Paclitaxel

Docetaxel

Paclitaxel and Docetaxel Segment by Application

Cervical Cancer

Ovarian Cancer

Breast Cancer

Others

Paclitaxel and Docetaxel Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paclitaxel and Docetaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paclitaxel and Docetaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paclitaxel and Docetaxel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paclitaxel and Docetaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Paclitaxel and Docetaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Paclitaxel Table 2. Major Company of Docetaxel Table 3. Global Paclitaxel and Docetaxel Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Paclitaxel and Docetaxel Sales by Type (2021-2026) & (K Tons) Table 5. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Type (2021-2026) Table 6. Global Paclitaxel and Docetaxel Sales by Type (2021-2026) & (US$ Million) Table 7. Global Paclitaxel and Docetaxel Sales Market Share in Value by Type (2021-2026) Table 8. Global Paclitaxel and Docetaxel Price by Type (2021-2026) & (US$/Ton) Table 9. Global Paclitaxel and Docetaxel Sales by Type (2027-2032) & (K Tons) Table 10. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Type (2027-2032) Table 11. Global Paclitaxel and Docetaxel Sales by Type (2027-2032) & (US$ Million) Table 12. Global Paclitaxel and Docetaxel Sales Market Share in Value by Type (2027-2032) Table 13. Global Paclitaxel and Docetaxel Price by Type (2027-2032) & (US$/Ton) Table 14. North America Paclitaxel and Docetaxel Sales by Type (2021-2026) & (K Tons) Table 15. North America Paclitaxel and Docetaxel Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Paclitaxel and Docetaxel Sales by Type (2021-2026) & (K Tons) Table 17. Europe Paclitaxel and Docetaxel Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Paclitaxel and Docetaxel Sales by Type (2021-2026) & (K Tons) Table 19. Asia-Pacific Paclitaxel and Docetaxel Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Paclitaxel and Docetaxel Sales by Type (2021-2026) & (K Tons) Table 21. Latin America Paclitaxel and Docetaxel Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Paclitaxel and Docetaxel Sales by Type (2021-2026) & (K Tons) Table 23. Middle East and Africa Paclitaxel and Docetaxel Sales by Type (2021-2026) & (US$ Million) Table 24. Paclitaxel and Docetaxel Industry Trends Table 25. Paclitaxel and Docetaxel Industry Drivers Table 26. Paclitaxel and Docetaxel Industry Opportunities and Challenges Table 27. Paclitaxel and Docetaxel Industry Restraints Table 28. Global Paclitaxel and Docetaxel Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Paclitaxel and Docetaxel Revenue Market Share by Company (2021-2026) Table 30. Global Paclitaxel and Docetaxel Sales by Company (2021-2026) & (K Tons) Table 31. Global Paclitaxel and Docetaxel Sales Share by Company (2021-2026) Table 32. Global Paclitaxel and Docetaxel Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Paclitaxel and Docetaxel Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Paclitaxel and Docetaxel Major Company Production Sites and Headquarters Table 35. Global Paclitaxel and Docetaxel Company, Product Type & Application Table 36. Global Paclitaxel and Docetaxel Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Paclitaxel and Docetaxel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Paclitaxel and Docetaxel Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Paclitaxel and Docetaxel Sales by Region (2021-2026) & (K Tons) Table 41. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Region (2021-2026) Table 42. Global Paclitaxel and Docetaxel Sales by Region (2021-2026) & (US$ Million) Table 43. Global Paclitaxel and Docetaxel Sales Market Share in Value by Region (2021-2026) Table 44. Global Paclitaxel and Docetaxel Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Paclitaxel and Docetaxel Sales by Region (2027-2032) & (K Tons) Table 46. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Region (2027-2032) Table 47. Global Paclitaxel and Docetaxel Sales by Region (2027-2032) & (US$ Million) Table 48. Global Paclitaxel and Docetaxel Sales Market Share in Value by Region (2027-2032) Table 49. Global Paclitaxel and Docetaxel Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Paclitaxel and Docetaxel Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Paclitaxel and Docetaxel Sales by Application (2021-2026) & (K Tons) Table 52. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Application (2021-2026) Table 53. Global Paclitaxel and Docetaxel Sales by Application (2021-2026) & (US$ Million) Table 54. Global Paclitaxel and Docetaxel Sales Market Share in Value by Application (2021-2026) Table 55. Global Paclitaxel and Docetaxel Price by Application (2021-2026) & (US$/Ton) Table 56. Global Paclitaxel and Docetaxel Sales by Application (2027-2032) & (K Tons) Table 57. Global Paclitaxel and Docetaxel Sales Market Share in Volume by Application (2027-2032) Table 58. Global Paclitaxel and Docetaxel Sales by Application (2027-2032) & (US$ Million) Table 59. Global Paclitaxel and Docetaxel Sales Market Share in Value by Application (2027-2032) Table 60. Global Paclitaxel and Docetaxel Price by Application (2027-2032) & (US$/Ton) Table 61. North America Paclitaxel and Docetaxel Sales by Application (2021-2026) & (K Tons) Table 62. North America Paclitaxel and Docetaxel Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Paclitaxel and Docetaxel Sales by Application (2021-2026) & (K Tons) Table 64. Europe Paclitaxel and Docetaxel Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Paclitaxel and Docetaxel Sales by Application (2021-2026) & (K Tons) Table 66. Asia-Pacific Paclitaxel and Docetaxel Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Paclitaxel and Docetaxel Sales by Application (2021-2026) & (K Tons) Table 68. Latin America Paclitaxel and Docetaxel Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Paclitaxel and Docetaxel Sales by Application (2021-2026) & (K Tons) Table 70. Middle East and Africa Paclitaxel and Docetaxel Sales by Application (2021-2026) & (US$ Million) Table 71. Yunnan Hande Company Information Table 72. Yunnan Hande Business Overview Table 73. Yunnan Hande Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Yunnan Hande Paclitaxel and Docetaxel Product Portfolio Table 75. Yunnan Hande Recent Development Table 76. Southpharma Company Information Table 77. Southpharma Business Overview Table 78. Southpharma Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Southpharma Paclitaxel and Docetaxel Product Portfolio Table 80. Southpharma Recent Development Table 81. Hainan Yew Pharm Company Information Table 82. Hainan Yew Pharm Business Overview Table 83. Hainan Yew Pharm Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Hainan Yew Pharm Paclitaxel and Docetaxel Product Portfolio Table 85. Hainan Yew Pharm Recent Development Table 86. TAPI (Teva) Company Information Table 87. TAPI (Teva) Business Overview Table 88. TAPI (Teva) Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. TAPI (Teva) Paclitaxel and Docetaxel Product Portfolio Table 90. TAPI (Teva) Recent Development Table 91. ScinoPharm Company Information Table 92. ScinoPharm Business Overview Table 93. ScinoPharm Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. ScinoPharm Paclitaxel and Docetaxel Product Portfolio Table 95. ScinoPharm Recent Development Table 96. Samyang Company Information Table 97. Samyang Business Overview Table 98. Samyang Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Samyang Paclitaxel and Docetaxel Product Portfolio Table 100. Samyang Recent Development Table 101. Polymed Company Information Table 102. Polymed Business Overview Table 103. Polymed Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Polymed Paclitaxel and Docetaxel Product Portfolio Table 105. Polymed Recent Development Table 106. Phyton Company Information Table 107. Phyton Business Overview Table 108. Phyton Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Phyton Paclitaxel and Docetaxel Product Portfolio Table 110. Phyton Recent Development Table 111. Novasep Company Information Table 112. Novasep Business Overview Table 113. Novasep Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Novasep Paclitaxel and Docetaxel Product Portfolio Table 115. Novasep Recent Development Table 116. Jiangsu Yew Biotechnology Company Information Table 117. Jiangsu Yew Biotechnology Business Overview Table 118. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product Portfolio Table 120. Jiangsu Yew Biotechnology Recent Development Table 121. Huiang biopharma Company Information Table 122. Huiang biopharma Business Overview Table 123. Huiang biopharma Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Huiang biopharma Paclitaxel and Docetaxel Product Portfolio Table 125. Huiang biopharma Recent Development Table 126. Fresenius-kabi Company Information Table 127. Fresenius-kabi Business Overview Table 128. Fresenius-kabi Paclitaxel and Docetaxel Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Fresenius-kabi Paclitaxel and Docetaxel Product Portfolio Table 130. Fresenius-kabi Recent Development Table 131. North America Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 132. North America Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 133. North America Paclitaxel and Docetaxel Sales Market Share by Country (2021-2026) Table 134. North America Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032) & (K Tons) Table 135. North America Paclitaxel and Docetaxel Sales Market Share Forecast by Country (2027-2032) Table 136. North America Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Paclitaxel and Docetaxel Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Paclitaxel and Docetaxel Market Share by Country (2021-2026) Table 139. North America Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Paclitaxel and Docetaxel Market Share Forecast by Country (2027-2032) Table 141. Europe Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 142. Europe Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 143. Europe Paclitaxel and Docetaxel Sales Market Share by Country (2021-2026) Table 144. Europe Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032) & (K Tons) Table 145. Europe Paclitaxel and Docetaxel Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Paclitaxel and Docetaxel Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Paclitaxel and Docetaxel Market Share by Country (2021-2026) Table 149. Europe Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Paclitaxel and Docetaxel Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 153. Asia-Pacific Paclitaxel and Docetaxel Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032) & (K Tons) Table 155. Asia-Pacific Paclitaxel and Docetaxel Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Paclitaxel and Docetaxel Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Paclitaxel and Docetaxel Market Share by Country (2021-2026) Table 159. Asia-Pacific Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Paclitaxel and Docetaxel Market Share Forecast by Country (2027-2032) Table 161. Latin America Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 162. Latin America Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 163. Latin America Paclitaxel and Docetaxel Sales Market Share by Country (2021-2026) Table 164. Latin America Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032) & (K Tons) Table 165. Latin America Paclitaxel and Docetaxel Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Paclitaxel and Docetaxel Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Paclitaxel and Docetaxel Market Share by Country (2021-2026) Table 169. Latin America Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Paclitaxel and Docetaxel Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 173. Middle East and Africa Paclitaxel and Docetaxel Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032) & (K Tons) Table 175. Middle East and Africa Paclitaxel and Docetaxel Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Paclitaxel and Docetaxel Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Paclitaxel and Docetaxel Market Share by Country (2021-2026) Table 179. Middle East and Africa Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Paclitaxel and Docetaxel Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Paclitaxel and Docetaxel Distributors List Table 184. Paclitaxel and Docetaxel Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Paclitaxel and Docetaxel Image Figure 2. Global Paclitaxel and Docetaxel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paclitaxel and Docetaxel Market Size (2021-2032) & (US$ Million) Figure 4. Global Paclitaxel and Docetaxel Sales (2021-2032) & (K Tons) Figure 5. Paclitaxel Image Figure 6. Global Paclitaxel Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Docetaxel Image Figure 8. Global Docetaxel Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Global Paclitaxel and Docetaxel Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Paclitaxel and Docetaxel Market Share by Type 2025 VS 2032 Figure 11. North America Paclitaxel and Docetaxel Sales Market Share in Volume by Type in 2025 Figure 12. North America Paclitaxel and Docetaxel Sales Market Share in Value by Type in 2025 Figure 13. Europe Paclitaxel and Docetaxel Sales Market Share in Volume by Type in 2025 Figure 14. Europe Paclitaxel and Docetaxel Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Paclitaxel and Docetaxel Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Paclitaxel and Docetaxel Sales Market Share in Value by Type in 2025 Figure 17. Latin America Paclitaxel and Docetaxel Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Paclitaxel and Docetaxel Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Paclitaxel and Docetaxel Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Paclitaxel and Docetaxel Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Paclitaxel and Docetaxel Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cervical Cancer Image Figure 24. Global Cervical Cancer Sales YoY Growth (2021-2032) & (K Tons) Figure 25. Ovarian Cancer Image Figure 26. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Breast Cancer Image Figure 28. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Tons) Figure 31. Global Paclitaxel and Docetaxel Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Paclitaxel and Docetaxel Market Share by Application 2025 VS 2032 Figure 33. North America Paclitaxel and Docetaxel Sales Market Share in Volume by Application in 2025 Figure 34. North America Paclitaxel and Docetaxel Sales Market Share in Value by Application in 2025 Figure 35. Europe Paclitaxel and Docetaxel Sales Market Share in Volume by Application in 2025 Figure 36. Europe Paclitaxel and Docetaxel Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Paclitaxel and Docetaxel Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Paclitaxel and Docetaxel Sales Market Share in Value by Application in 2025 Figure 39. Latin America Paclitaxel and Docetaxel Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Paclitaxel and Docetaxel Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Paclitaxel and Docetaxel Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Paclitaxel and Docetaxel Sales Market Share in Value by Application in 2025 Figure 43. North America Paclitaxel and Docetaxel Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 44. North America Paclitaxel and Docetaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Paclitaxel and Docetaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Paclitaxel and Docetaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Paclitaxel and Docetaxel Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 48. Europe Paclitaxel and Docetaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Paclitaxel and Docetaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Paclitaxel and Docetaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Paclitaxel and Docetaxel Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 52. Asia-Pacific Paclitaxel and Docetaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Paclitaxel and Docetaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Paclitaxel and Docetaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Paclitaxel and Docetaxel Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 56. Latin America Paclitaxel and Docetaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Paclitaxel and Docetaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Paclitaxel and Docetaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Paclitaxel and Docetaxel Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 60. Middle East and Africa Paclitaxel and Docetaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Paclitaxel and Docetaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Paclitaxel and Docetaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Paclitaxel and Docetaxel Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Paclitaxel and Docetaxel Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Paclitaxel
  • Docetaxel
Applications
  • Cervical Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Others
Companies covered
  • Yunnan Hande
  • Southpharma
  • Hainan Yew Pharm
  • TAPI (Teva)
  • ScinoPharm
  • Samyang
  • Polymed
  • Phyton
  • Novasep
  • Jiangsu Yew Biotechnology
  • Huiang biopharma
  • Fresenius-kabi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Paclitaxel and Docetaxel Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Paclitaxel and Docetaxel Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Paclitaxel and Docetaxel Market by Type
  6. 1.3.1 Paclitaxel
  7. 1.3.2 Docetaxel
  8. 1.4 Global Paclitaxel and Docetaxel Market Size by Type
  9. 1.4.1 Global Paclitaxel and Docetaxel Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Paclitaxel and Docetaxel Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Paclitaxel and Docetaxel Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Paclitaxel and Docetaxel Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Paclitaxel and Docetaxel Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Paclitaxel and Docetaxel Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Paclitaxel and Docetaxel Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Paclitaxel and Docetaxel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Paclitaxel and Docetaxel Industry Trends
  2. 2.2 Paclitaxel and Docetaxel Industry Drivers
  3. 2.3 Paclitaxel and Docetaxel Industry Opportunities and Challenges
  4. 2.4 Paclitaxel and Docetaxel Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Paclitaxel and Docetaxel Revenue (2021-2026)
  2. 3.2 Global Top Players by Paclitaxel and Docetaxel Sales (2021-2026)
  3. 3.3 Global Top Players by Paclitaxel and Docetaxel Price (2021-2026)
  4. 3.4 Global Paclitaxel and Docetaxel Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paclitaxel and Docetaxel Major Company Production Sites & Headquarters
  6. 3.6 Global Paclitaxel and Docetaxel Company, Product Type & Application
  7. 3.7 Global Paclitaxel and Docetaxel Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paclitaxel and Docetaxel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paclitaxel and Docetaxel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paclitaxel and Docetaxel Tier 1, Tier 2, and Tier 3
4 Paclitaxel and Docetaxel Regional Status and Outlook
  1. 4.1 Global Paclitaxel and Docetaxel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Paclitaxel and Docetaxel Historic Market Size by Region
  3. 4.2.1 Global Paclitaxel and Docetaxel Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Paclitaxel and Docetaxel Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Paclitaxel and Docetaxel Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Paclitaxel and Docetaxel Forecasted Market Size by Region
  7. 4.3.1 Global Paclitaxel and Docetaxel Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Paclitaxel and Docetaxel Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Paclitaxel and Docetaxel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Paclitaxel and Docetaxel by Application
  1. 5.1 Paclitaxel and Docetaxel Market by Application
  2. 5.1.1 Cervical Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Others
  6. 5.2 Global Paclitaxel and Docetaxel Market Size by Application
  7. 5.2.1 Global Paclitaxel and Docetaxel Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Paclitaxel and Docetaxel Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Paclitaxel and Docetaxel Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Paclitaxel and Docetaxel Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Paclitaxel and Docetaxel Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Paclitaxel and Docetaxel Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Paclitaxel and Docetaxel Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Paclitaxel and Docetaxel Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yunnan Hande
  2. 6.1.1 Yunnan Hande Company Information
  3. 6.1.2 Yunnan Hande Business Overview
  4. 6.1.3 Yunnan Hande Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yunnan Hande Paclitaxel and Docetaxel Product Portfolio
  6. 6.1.5 Yunnan Hande Recent Developments
  7. 6.2 Southpharma
  8. 6.2.1 Southpharma Company Information
  9. 6.2.2 Southpharma Business Overview
  10. 6.2.3 Southpharma Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Southpharma Paclitaxel and Docetaxel Product Portfolio
  12. 6.2.5 Southpharma Recent Developments
  13. 6.3 Hainan Yew Pharm
  14. 6.3.1 Hainan Yew Pharm Company Information
  15. 6.3.2 Hainan Yew Pharm Business Overview
  16. 6.3.3 Hainan Yew Pharm Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hainan Yew Pharm Paclitaxel and Docetaxel Product Portfolio
  18. 6.3.5 Hainan Yew Pharm Recent Developments
  19. 6.4 TAPI (Teva)
  20. 6.4.1 TAPI (Teva) Company Information
  21. 6.4.2 TAPI (Teva) Business Overview
  22. 6.4.3 TAPI (Teva) Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 TAPI (Teva) Paclitaxel and Docetaxel Product Portfolio
  24. 6.4.5 TAPI (Teva) Recent Developments
  25. 6.5 ScinoPharm
  26. 6.5.1 ScinoPharm Company Information
  27. 6.5.2 ScinoPharm Business Overview
  28. 6.5.3 ScinoPharm Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ScinoPharm Paclitaxel and Docetaxel Product Portfolio
  30. 6.5.5 ScinoPharm Recent Developments
  31. 6.6 Samyang
  32. 6.6.1 Samyang Company Information
  33. 6.6.2 Samyang Business Overview
  34. 6.6.3 Samyang Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Samyang Paclitaxel and Docetaxel Product Portfolio
  36. 6.6.5 Samyang Recent Developments
  37. 6.7 Polymed
  38. 6.7.1 Polymed Company Information
  39. 6.7.2 Polymed Business Overview
  40. 6.7.3 Polymed Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Polymed Paclitaxel and Docetaxel Product Portfolio
  42. 6.7.5 Polymed Recent Developments
  43. 6.8 Phyton
  44. 6.8.1 Phyton Company Information
  45. 6.8.2 Phyton Business Overview
  46. 6.8.3 Phyton Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Phyton Paclitaxel and Docetaxel Product Portfolio
  48. 6.8.5 Phyton Recent Developments
  49. 6.9 Novasep
  50. 6.9.1 Novasep Company Information
  51. 6.9.2 Novasep Business Overview
  52. 6.9.3 Novasep Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novasep Paclitaxel and Docetaxel Product Portfolio
  54. 6.9.5 Novasep Recent Developments
  55. 6.10 Jiangsu Yew Biotechnology
  56. 6.10.1 Jiangsu Yew Biotechnology Company Information
  57. 6.10.2 Jiangsu Yew Biotechnology Business Overview
  58. 6.10.3 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product Portfolio
  60. 6.10.5 Jiangsu Yew Biotechnology Recent Developments
  61. 6.11 Huiang biopharma
  62. 6.11.1 Huiang biopharma Company Information
  63. 6.11.2 Huiang biopharma Business Overview
  64. 6.11.3 Huiang biopharma Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Huiang biopharma Paclitaxel and Docetaxel Product Portfolio
  66. 6.11.5 Huiang biopharma Recent Developments
  67. 6.12 Fresenius-kabi
  68. 6.12.1 Fresenius-kabi Company Information
  69. 6.12.2 Fresenius-kabi Business Overview
  70. 6.12.3 Fresenius-kabi Paclitaxel and Docetaxel Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Fresenius-kabi Paclitaxel and Docetaxel Product Portfolio
  72. 6.12.5 Fresenius-kabi Recent Developments
7 North America by Country
  1. 7.1 North America Paclitaxel and Docetaxel Sales by Country
  2. 7.1.1 North America Paclitaxel and Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Paclitaxel and Docetaxel Sales by Country (2021-2026)
  4. 7.1.3 North America Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032)
  5. 7.2 North America Paclitaxel and Docetaxel Market Size by Country
  6. 7.2.1 North America Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Paclitaxel and Docetaxel Market Size by Country (2021-2026)
  8. 7.2.3 North America Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Paclitaxel and Docetaxel Sales by Country
  2. 8.1.1 Europe Paclitaxel and Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Paclitaxel and Docetaxel Sales by Country (2021-2026)
  4. 8.1.3 Europe Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Paclitaxel and Docetaxel Market Size by Country
  6. 8.2.1 Europe Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Paclitaxel and Docetaxel Market Size by Country (2021-2026)
  8. 8.2.3 Europe Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Paclitaxel and Docetaxel Sales by Country
  2. 9.1.1 Asia-Pacific Paclitaxel and Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Paclitaxel and Docetaxel Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Paclitaxel and Docetaxel Market Size by Country
  6. 9.2.1 Asia-Pacific Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Paclitaxel and Docetaxel Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Paclitaxel and Docetaxel Sales by Country
  2. 10.1.1 South America Paclitaxel and Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Paclitaxel and Docetaxel Sales by Country (2021-2026)
  4. 10.1.3 South America Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032)
  5. 10.2 South America Paclitaxel and Docetaxel Market Size by Country
  6. 10.2.1 South America Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Paclitaxel and Docetaxel Market Size by Country (2021-2026)
  8. 10.2.3 South America Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Paclitaxel and Docetaxel Sales by Country
  2. 11.1.1 Middle East and Africa Paclitaxel and Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Paclitaxel and Docetaxel Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Paclitaxel and Docetaxel Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Paclitaxel and Docetaxel Market Size by Country
  6. 11.2.1 Middle East and Africa Paclitaxel and Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Paclitaxel and Docetaxel Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Paclitaxel and Docetaxel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Paclitaxel and Docetaxel Value Chain Analysis
  2. 12.1.1 Paclitaxel and Docetaxel Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Paclitaxel and Docetaxel Production Mode & Process
  7. 12.2 Paclitaxel and Docetaxel Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Paclitaxel and Docetaxel Distributors
  10. 12.2.3 Paclitaxel and Docetaxel Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst